Skip to main content
Clinical Trials/NCT05628168
NCT05628168
Completed
Not Applicable

Effect of Neurodynamic Mobilization Techniques in Patients With Diabetic Neuropathy

October 6 University1 site in 1 country42 target enrollmentDecember 5, 2021

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Diabetic Neuropathies
Sponsor
October 6 University
Enrollment
42
Locations
1
Primary Endpoint
Effect of Neurodynamic Mobilization Techniques in Patients With Diabetic Neuropathy
Status
Completed
Last Updated
3 years ago

Overview

Brief Summary

Neurodynamic mobilization Techniques and Selected Physical program used as a treatment for diabetic neuropathy patients and assessed by nerve condition study and function outcome.

Detailed Description

Neurodynamic mobilization Techniques and Selected Physical program used as a treatment for diabetic neuropathy patients and assessed by nerve condition study and function outcome.

Registry
clinicaltrials.gov
Start Date
December 5, 2021
End Date
June 2, 2022
Last Updated
3 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Ahmed Magdy Alshimy

Lecturer of Physical Therapy at department of Neurology

October 6 University

Eligibility Criteria

Inclusion Criteria

  • Diagnosed with T2DM for ≥10 years determined by electrophysiological measurements were enrolled.
  • The participants regularly took their diabetes medications during the assessment and treatment period.

Exclusion Criteria

  • Uncontrolled T2DM and diagnosed with T2DM for \< 10 years.
  • Patients with neural, muscular, and skeletal system deformities; radiculopathy; and psychiatric disorders.

Outcomes

Primary Outcomes

Effect of Neurodynamic Mobilization Techniques in Patients With Diabetic Neuropathy

Time Frame: 5-6 months

This study aimed to investigate neurodynamic mobilization effect on sensory and motor nerve conduction study, pain, and functional activity in patients with type 2 diabetic neuropathy and will be assessed through Katz index and NIHON KODEN EMG device.

Study Sites (1)

Loading locations...

Similar Trials